The U.S. Food and Drug Administration (FDA) today approved INVEGA? (paliperidone) Extended-Release Tablets, a new once-daily, atypical antipsychotic, for the long-term maintenance treatment of schizophrenia. INVEGA? is now indicated for both acute (short-term) and maintenance (long-term) treatment of schizophrenia. [click link for full article]
From: www.medicalnewstoday.com
paliperidone) For Long-Term Maintenance Treatment Of Schizophrenia
Posted by Ruslan Abuzant at 1:50 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment